Company intelligence / Profile preview

APEX Biologix

Woods Cross, Utah, United Statesapexbiologix.com ↗
Ownership
Private
Employees
~25
Development stage
Commercial
01

Overview

APEX Biologix has developed and commercialized FDA-cleared Class II medical devices for regenerative medicine, including the XCELL PRP kit. The company’s products are widely used in orthopedics, sports medicine, and wound care. They have expanded into Europe and veterinary markets, with over 2,000 active physician clients globally. Clinical results focus on consistent platelet concentration and streamlined procedures for improved patient outcomes.

Therapeutic areas
OtherDermatology
Modalities
Platelet-rich plasma (PRP) therapy (Biologic)Bone marrow concentrate therapy (Biologic)Protein concentrate therapy (Biologic)Allograft products (Biologic)
Industry
Therapeutic Medical Devices
02

Drug pipeline

3 assets

XCELL PRP

Commercial
Indications
Regenerative medicine

2 more assets in the full pipeline.

03

Partnerships

Mayo Clinic – know-how license agreement for regenerative product developmentBioventus LLC – exclusive U.S. distribution agreement for the XCELL PRP system in orthopedics/sports medicine

Beyond the preview

Go deeper on APEX Biologix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on APEX Biologix.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call